Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in adult Fontan patients to improve aerobic capacity
NL-OMON24216Not yet recruiting
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bosentan in Cardiovascular Malformation (CVM) and Fontan circulation (2 arms), sponsored by none. Primary endpoint: Change in aerobic capacity. Planned start Dec 2008; status: not yet recruiting.
02
Drugs
bosentan
03
Conditions
Cardiovascular Malformation (CVM)Fontan circulation
Beyond the preview
Go deeper on NL-OMON24216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24216.